Jim Farley

Mr. Jim Farley

President, Cardinal Consulting and Training


          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Member of the Healthcare Council

Request a consultation with Jim Farley

Council Member Biography

Jim Farley is an Independent Consultant and Owner of Cardinal Consulting and Training. Formerly, Mr. Farley served as the Director of the Science Branch of Philadelphia District FDA. He has over 30 years of experience in pharmaceutical and pharmaceutical packaging industries with extensive experience in the areas of laboratory management and Food and Drug Administration regulations. Mr. Farley has held various technical management positions in quality control, technical service, and as the Director of Research and Development in pharmaceutical packaging. (This is me - Update Profile)


Employment History

1996 - Unspecified
President, Cardinal Consulting and Training

GLG NewsSM Analyses by Jim Farley

Opinions and analyses expressed in G+ Insights are solely those of the author. See the Terms of Use for details.


GLG News is now G+ Insights

G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.

Watson Pharmaceutical's Acquisition of Andrx

May 17, 2006

Watson to Acquire Drug Rival Andrx | pubs.acs.org

If the deal goes through, the estimated year 2007 revenues, according to Watson, would be $2.8 billion.

India is strong in Pharmaceutical Area

May 11, 2006

Science in India | www.cen-online.org

More sources of Pharmaceutical Materials such as Active Pharmaceutical Ingredients (API). Possible better prices.